-
Electronic (PDF)
-
Site License
-
Enterprisewide
Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010
GlobalData, December 2010, Pages: 57
Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010
Summary
Our clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010" provides data on the Neuroendocrine Carcinoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Neuroendocrine Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Neuroendocrine Carcinoma).
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
List of Tables
List of Figures
Introduction
Neuroendocrine Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Neuroendocrine Carcinoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Neuroendocrine Carcinoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Ipsen Limited
Clinical Trial Overview of Ipsen Limited
Novartis AG
Clinical Trial Overview of Novartis AG
Callisto Pharmaceuticals, Inc.
Clinical Trial Overview of Callisto Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc.
Clinical Trial Overview of Molecular Insight Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc.
Clinical Trial Overview of Cylene Pharmaceuticals, Inc.
Neotropix, Inc.
Clinical Trial Overview of Neotropix, Inc.
iOMEDICO AG
Clinical Trial Overview of iOMEDICO AG
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Stanford University
Clinical Trial Overview of Stanford University
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
The University of Iowa
Clinical Trial Overview of The University of Iowa
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
The University of Western Ontario
Clinical Trial Overview of The University of Western Ontario
University of Turin
Clinical Trial Overview of University of Turin
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
University Hospital Inselspital, Berne
Clinical Trial Overview of University Hospital Inselspital, Berne
Assistance Publique Hopitaux De Marseille
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
Columbia University
Clinical Trial Overview of Columbia University
Eastern Cooperative Oncology Group
Clinical Trial Overview of Eastern Cooperative Oncology Group
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of New Mexico
Clinical Trial Overview of University of New Mexico
Assistance Publique - Hopitaux de Paris
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
